We could arguably put this phase 1 trial down as a phase 2...It's increasingly looking that way.
It's an expanded phase 1 trial, keep this in mind.
It's also targeting a rare and unmet need in TCL cancers.
So when you have these levels of efficacy, in a expanded trial targeting these types of cancer...That's got blanket orphan status from FDA...I think we can confidently say next stop is registrational trial, skipping phase 2.
This means a massive saving in the tens of millions on a phase 2 trial.
This also likely means a much much smaller registrational trial than tradition...Due to it being unmet need of TCL...Likely a further saving in the tens of millions.
So we could have a drug that's quickly fast tracked to market by the FDA...This story could move at a rapid rate of knots.
Another important consideration...Not only is PTX-100 targeting an unmet need...But even if that need were suddenly met by competitors eg. A CAR-T program...It must be remembered that current CAR-T therapies are often $500k per dose...PTX-100 wouldn't come close and could be a very cost effective option for oncologist and patients without the deep pockets for more expensive options...The future looks very promising indeed.
- Forums
- ASX - By Stock
- PTX
- Ann: Continued promising results in PTX-100 TCL trial
Ann: Continued promising results in PTX-100 TCL trial, page-38
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.0¢ | $26.10K | 626.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 774458 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 50033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 774458 | 0.040 |
8 | 627589 | 0.039 |
4 | 373000 | 0.038 |
4 | 289000 | 0.037 |
2 | 375000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 50033 | 2 |
0.042 | 25000 | 1 |
0.043 | 70651 | 2 |
0.044 | 227665 | 2 |
0.045 | 831675 | 6 |
Last trade - 15.38pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Is oil undervalued?
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
PTX (ASX) Chart |